Page last updated: 2024-08-24

telmisartan and Stroke

telmisartan has been researched along with Stroke in 60 studies

Research

Studies (60)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	28 (46.67)	29.6817
2010's	31 (51.67)	24.3611
2020's	1 (1.67)	2.80

Authors

Authors	Studies
Lee, TH; Li, YR; Lin, YS; Liu, CH; Sung, PS; Wei, YC	1
Böhm, M; Lonn, E; Mahfoud, F; Mancia, G; Mann, JFE; Redon, J; Schmieder, R; Schumacher, H; Sliwa, K; Teo, KK; Weber, M; Williams, B; Yusuf, S	1
Böhm, M; Lonn, EM; Mahfoud, F; Mancia, G; Mann, JFE; Marx, N; Redon, J; Schmieder, RE; Schumacher, H; Sliwa, K; Teo, KK; Weber, MA; Williams, B; Yusuf, S	1
Antoniou, T; Camacho, X; Gomes, T; Juurlink, DN; Mamdani, MM; Yao, Z	1
Bath, PM; Cotton, D; Diener, HC; Ovbiagele, B; Sha, N	1
Ito, T; Kawahara, K; Kikuchi, K; Maruyama, I; Miura, N; Morimoto-Yamashita, Y; Murai, Y; Tanaka, E; Tancharoen, S	1
Clase, C; Dagenais, GR; de Zeeuw, D; Gao, P; Heerspink, HJ; Lonn, E; Mann, JF; Sleight, P; Teo, KT; Yusuf, S	1
Haririan, A; Karadsheh, FF; Reddivari, V; Salzberg, DJ; Weir, MR	1
Böhm, M; Foulquier, S; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Unger, T; Yusuf, S	1
Bath, PM; Cotton, D; Estol, CJ; Gorelick, PB; Martin, RH	1
Bath, PM; Cotton, D; Dahlof, B; Estol, CJ; Gorelick, PB; Martin, RH; Weber, MA	1
Abe, K; Deguchi, K; Hishikawa, N; Kurata, T; Morimoto, N; Ohta, Y; Yamashita, T; Zhai, Y	1
Abe, K; Deguchi, K; Fukui, Y; Hishikawa, N; Kono, S; Kurata, T; Liu, W; Omote, Y; Sato, K; Yamashita, T; Zhai, Y	1
Lackland, DT	1
Angeli, F; Gao, P; Mancia, G; Pogue, J; Reboldi, G; Sleight, P; Teo, K; Trimarco, B; Verdecchia, P; Yusuf, S	1
Abe, K; Deguchi, K; Hishikawa, N; Kurata, T; Omote, Y; Sato, K; Yamashita, T	1
Brunner, HR; Foster, C; Huo, Y; Michel, MC	1
Chen, CH; Cheng, HM; Hoshide, S; Huang, QF; Kario, K; Park, CG; Park, S; Wang, JG	1
Kent, DM; Thaler, DE	1
Albers, GW; Bath, P; Bornstein, N; Chan, BP; Chen, ST; Cotton, D; Cunha, L; Dahlöf, B; De Keyser, J; Diener, HC; Donnan, GA; Estol, C; Gorelick, P; Gu, V; Hermansson, K; Hilbrich, L; Kaste, M; Lawton, WA; Lu, C; Machnig, T; Martin, RH; Ounpuu, S; Pais, P; Palesch, Y; Roberts, R; Sacco, RL; Skvortsova, V; Teal, P; Toni, D; Vandermaelen, C; Voigt, T; Weber, M; Yoon, BW; Yusuf, S	3
Kappelle, LJ	1
Atar, D; Hanley, DF; Serebruany, VL	1
Lees, KR	1
McInnes, GT	1
Doumas, M; Papademetriou, V	1
Bressolle, C; Fichet, J	1
Achard, JM; Fournier, A; Fournier, RO	1
Anderson, C; Cukierman-Yaffe, T; Gerstein, HC; Hilbrich, L; Jackson, SH; Sleight, P; Teo, K; Yusuf, S; Zhao, F	1
Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S	1
Auffarth, GU; Bettendorf, M; Grundt, C; Inta, I; Lemmer, B; Schwaninger, M; Veltkamp, R; Weber, D; Winteroll, S	1
Diener, HC	2
Hori, T; Kawamata, T; Kobayashi, M; Kobayashi, T; Okada, Y; Shibata, N	1
Bath, PM; Cotton, D; Diener, HC; Estol, C; Martin, RH; Palesch, Y; Roberts, R; Sacco, R; Toni, D; Yusuf, S	1
Jugdutt, BI	1
Clase, CM; Gao, P; Grosshennig, A; Mann, JF; McQueen, M; Teo, KK; Tobe, SW; Wang, X; Yusuf, S	1
Godes, M; Krikov, M; Mueller, S; Namsolleck, P; Rumschüssel, K; Schmerbach, K; Steckelings, U; Thoene-Reineke, C; Unger, T; Villringer, A; Wengenmayer, C	1
Jennings, G; Liu, GL; Mancia, G; Redon, J; Ryden, L; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Verdecchia, P; Yusoff, K; Yusuf, S	1
Avezum, A; Dans, A; Ferreira, R; Gafni, A; Gao, P; Lamy, A; Teo, K; Tong, W; Wang, X; Young, J; Yusuf, S	1
Bath, PM; Cotton, D; Diener, HC; Donnan, GA; Martin, RH; Ovbiagele, B; Vinisko, R; Yusuf, S	1
Blatchford, J; Demchuk, AM; Diehl, A; Diener, HC; Forsting, M; Gizewski, ER; Hermansson, K; Möller-Hartmann, C; Sacco, RL; Saver, JL; Wanke, I; Warach, S; Weber, R; Weimar, C	2
Binbrek, AS; Chazova, I; Dagenais, G; Dans, AL; Ferreira, R; Gao, P; Healey, J; Holwerda, N; Iacobellis, G; Karatzas, N; Keltai, M; Mancia, G; Sleight, P; Teo, K; Verdecchia, P; Yusuf, S	1
Deguchi, I; Fukuoka, T; Furuya, D; Tanahashi, N	1
Böhm, M; Kappert, K; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Unger, T; Yusuf, S	1
Guirguis-Blake, J	1
Kamal, AK; Wadiwala, MF	1
Hankey, GJ	1
Chrysant, GS; Chrysant, SG; Desai, A	1
Devereux, RB; Krauser, DG	1
Diener, HC; Sacco, R; Yusuf, S	1
Dahlöf, B	1

Reviews

11 review(s) available for telmisartan and Stroke

Article	Year
Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke. International journal of molecular sciences, 2013, Sep-13, Volume: 14, Issue:9 Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; HMGB1 Protein; Humans; Hypertension; Irbesartan; Neurons; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors; Stroke; Telmisartan; Tetrazoles	2013
Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease. Pharmacology & therapeutics, 2016, Volume: 164 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atherosclerosis; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Culture Techniques; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Gene Knockout Techniques; Glucose; Humans; Hypertension; Kidney; Lipid Metabolism; Metabolic Diseases; Oxadiazoles; Renin-Angiotensin System; Stroke; Telmisartan	2016
Target Blood Pressure in Patients with Diabetes: Asian Perspective. Yonsei medical journal, 2016, Volume: 57, Issue:6 Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypotension; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Reference Values; Risk Factors; Stroke; Telmisartan	2016
Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2009, Volume: 27, Issue:5 Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Telmisartan	2009
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly. Clinical interventions in aging, 2010, Dec-03, Volume: 5 Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Polypharmacy; PPAR gamma; Prevalence; Renin-Angiotensin System; Sex Factors; Stroke; Telmisartan	2010
Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease. American family physician, 2012, Jul-01, Volume: 86, Issue:1 Topics: Adrenergic beta-Antagonists; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Cough; Dizziness; Drug Therapy, Combination; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Patient Readmission; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Telmisartan	2012
Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE? Stroke, 2003, Volume: 34, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Life Style; Practice Guidelines as Topic; Ramipril; Risk; Risk Factors; Stroke; Telmisartan	2003
Current status of angiotensin receptor blockers for the treatment of cardiovascular diseases: focus on telmisartan. Journal of human hypertension, 2005, Volume: 19, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Heart Failure; Humans; Hypertension; Renal Insufficiency; Stroke; Telmisartan; Treatment Outcome	2005
Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz, 2006, Volume: 31, Issue:4 Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan	2006
Prevention of stroke in patients with hypertension. The American journal of cardiology, 2007, Aug-06, Volume: 100, Issue:3A Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Europe; Humans; Hypertension; Stroke; Telmisartan	2007
The PRoFESS trial: future impact on secondary stroke prevention. Expert review of neurotherapeutics, 2007, Volume: 7, Issue:9 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Forecasting; Humans; Internationality; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Treatment Outcome; Vasodilator Agents	2007

Trials

21 trial(s) available for telmisartan and Stroke

Article	Year
Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. European heart journal, 2018, 09-01, Volume: 39, Issue:33 Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Ramipril; Risk Assessment; Single-Blind Method; Stroke; Telmisartan; Treatment Outcome	2018
Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. European heart journal, 2019, 07-01, Volume: 40, Issue:25 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus; Diastole; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hypertension; Myocardial Infarction; Peripheral Arterial Disease; Ramipril; Retrospective Studies; Risk Factors; Stroke; Systole; Telmisartan	2019
Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation. Stroke, 2013, Volume: 44, Issue:11 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cohort Studies; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Male; Middle Aged; Proportional Hazards Models; Recurrence; Renin-Angiotensin System; Risk Factors; Stroke; Telmisartan; Time Factors	2013
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. European journal of preventive cardiology, 2014, Volume: 21, Issue:3 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Drug Therapy, Combination; Female; Heart Failure; Hospitalization; Humans; Hyperkalemia; Hypertension; Hypokalemia; Kidney; Kidney Diseases; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Nonlinear Dynamics; Odds Ratio; Potassium; Proportional Hazards Models; Ramipril; Renal Dialysis; Renin-Angiotensin System; Risk Assessment; Risk Factors; Stroke; Telmisartan; Time Factors; Treatment Outcome	2014
Specific management of anemia and hypertension in renal transplant recipients: influence of renin-angiotensin system blockade. American journal of nephrology, 2014, Volume: 39, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anemia; Benzimidazoles; Benzoates; Darbepoetin alfa; Double-Blind Method; Erythropoietin; Female; Hemoglobins; Humans; Hypertension; Kidney Transplantation; Male; Middle Aged; Myocardial Infarction; Renin-Angiotensin System; Stroke; Telmisartan; Treatment Outcome; Young Adult	2014
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis. Journal of hypertension, 2014, Volume: 32, Issue:6 Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cardiovascular System; Coronary Artery Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Telmisartan; Treatment Outcome	2014
Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial. International journal of stroke : official journal of the International Stroke Society, 2014, Volume: 9 Suppl A100 Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Ethnicity; Female; Humans; Intracranial Hemorrhages; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Stroke; Telmisartan	2014
Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study. Blood pressure monitoring, 2014, Volume: 19, Issue:5 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Brain Ischemia; Diagnosis, Differential; Double-Blind Method; Ethnicity; False Negative Reactions; Female; Follow-Up Studies; Global Health; Humans; Hypertension; Male; Office Visits; Outpatient Clinics, Hospital; Platelet Aggregation Inhibitors; Racial Groups; Reproducibility of Results; Socioeconomic Factors; Sphygmomanometers; Stroke; Telmisartan; Thrombophilia; Treatment Outcome; White Coat Hypertension	2014
Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:1 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Coronary Artery Disease; Diastole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Ramipril; Stroke; Systole; Telmisartan; Time Factors; Treatment Outcome	2015
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. The New England journal of medicine, 2008, Sep-18, Volume: 359, Issue:12 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Vascular Diseases	2008
Telmisartan to prevent recurrent stroke and cardiovascular events. The New England journal of medicine, 2008, Sep-18, Volume: 359, Issue:12 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Female; Follow-Up Studies; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Potassium; Secondary Prevention; Stroke; Telmisartan; Treatment Failure	2008
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFE The Lancet. Neurology, 2008, Volume: 7, Issue:10 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Cognition; Dipyridamole; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; International Cooperation; Male; Mental Status Schedule; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Secondary Prevention; Severity of Illness Index; Stroke; Telmisartan; Ticlopidine	2008
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke, 2009, Volume: 40, Issue:11 Topics: Aged; Benzimidazoles; Benzoates; Blood Pressure; Brain Ischemia; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Secondary Prevention; Stroke; Telmisartan	2009
Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies. Circulation, 2011, Mar-15, Volume: 123, Issue:10 Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Ramipril; Stroke; Telmisartan; Treatment Outcome	2011
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation, 2011, Oct-18, Volume: 124, Issue:16 Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Guidelines as Topic; Humans; Incidence; Kidney Diseases; Middle Aged; Ramipril; Risk; Stroke; Telmisartan	2011
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy. Stroke, 2012, Volume: 43, Issue:2 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Cerebral Infarction; Clopidogrel; Dipyridamole; Female; Humans; Intracranial Embolism; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Socioeconomic Factors; Stroke; Telmisartan; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents	2012
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtoleran Journal of hypertension, 2012, Volume: 30, Issue:5 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anthropometry; Atrial Fibrillation; Benzimidazoles; Benzoates; Body Mass Index; Cardiovascular Diseases; Diabetes Complications; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Middle Aged; Placebos; Ramipril; Risk; Risk Factors; Stroke; Telmisartan; Vitamin K	2012
Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy. Stroke, 2012, Volume: 43, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; Brain; Disease Progression; Female; Follow-Up Studies; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Stroke; Telmisartan; Treatment Outcome	2012
Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combinatio Circulation, 2012, Aug-21, Volume: 126, Issue:8 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Ramipril; Research Design; Risk Assessment; Risk Factors; Sex Distribution; Sex Factors; Stroke; Telmisartan	2012
What is better antiplatelet agent to prevent recurrent stroke? JPMA. The Journal of the Pakistan Medical Association, 2012, Volume: 62, Issue:9 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; Clopidogrel; Dipyridamole; Double-Blind Method; Evidence-Based Medicine; Humans; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Treatment Outcome	2012
Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with Cerebrovascular diseases (Basel, Switzerland), 2007, Volume: 23, Issue:5-6 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Research Design; Secondary Prevention; Stroke; Telmisartan; Ticlopidine; Treatment Outcome	2007

Other Studies

28 other study(ies) available for telmisartan and Stroke

Article	Year
Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study. Cardiovascular diabetology, 2020, 01-07, Volume: 19, Issue:1 Topics: Aged; Antihypertensive Agents; Brain Ischemia; Databases, Factual; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Stroke; Taiwan; Telmisartan; Time Factors; Treatment Outcome	2020
Comparison of pre- and post-ischemic treatment of telmisartan and nimodipine combination in experimentally induced cerebral ischemia. Indian journal of experimental biology, 2016, Volume: 54, Issue:9 Topics: Animals; Benzimidazoles; Benzoates; Brain Ischemia; Drug Combinations; Energy Metabolism; Excitatory Amino Acids; Glutathione; Male; Motor Activity; Neuroprotective Agents; Nimodipine; Rats; Rats, Sprague-Dawley; Stroke; Telmisartan	2016
Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, Sep-03, Volume: 185, Issue:12 Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetic Angiopathies; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Irbesartan; Losartan; Male; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Stroke; Telmisartan; Tetrazoles; Treatment Outcome	2013
Strong improvement of apolipoprotein E/low-density lipoprotein receptor signals by telmisartan in poststroke spontaneously hypertensive stroke resistant. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Benzimidazoles; Benzoates; Cerebral Cortex; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Male; Mitogen-Activated Protein Kinase 1; Rats; Rats, Inbred SHR; Receptors, LDL; Reperfusion Injury; Signal Transduction; Stroke; Telmisartan	2014
Strong reduction of low-density lipoprotein receptor/apolipoprotein E expressions by telmisartan in cerebral cortex and hippocampus of stroke resistant spontaneously hypertensive rats. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2014, Volume: 23, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Benzimidazoles; Benzoates; Cerebral Cortex; Dementia, Vascular; Dose-Response Relationship, Drug; Hippocampus; Male; Mitogen-Activated Protein Kinase 1; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, LDL; Stroke; Telmisartan	2014
Systolic blood pressure target levels: evidence for benefits in stroke. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:1 Topics: Benzimidazoles; Benzoates; Blood Pressure; Coronary Artery Disease; Female; Humans; Male; Myocardial Infarction; Ramipril; Stroke; Telmisartan	2015
Telmisartan promotes potential glucose homeostasis in stroke-resistant spontaneously hypertensive rats via peroxisome proliferator-activated receptor γ activation. Current neurovascular research, 2015, Volume: 12, Issue:1 Topics: Age Factors; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Glucose; Homeostasis; Male; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; Stroke; Telmisartan	2015
Stroke prevention--insights from incoherence. The New England journal of medicine, 2008, Sep-18, Volume: 359, Issue:12 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk; Secondary Prevention; Stroke; Telmisartan; Ticlopidine	2008
[Inhibition of platelet aggregation and angiotensin II-receptor blockade following TIA; the unexpected results of the Prevention Regimen For Effectively Avoiding Second Strokes (PROFESS) trial]. Nederlands tijdschrift voor geneeskunde, 2008, Aug-30, Volume: 152, Issue:35 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Headache; Humans; Platelet Aggregation Inhibitors; Stroke; Telmisartan; Ticlopidine	2008
Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering? Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 26, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials, Phase IV as Topic; Drug Therapy, Combination; Humans; Hypertension; Ramipril; Randomized Controlled Trials as Topic; Stroke; Telmisartan; Treatment Outcome	2008
PRoFESS. Stroke, 2009, Volume: 40, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Telmisartan; Ticlopidine; Treatment Outcome	2009
Telmisartan to prevent recurrent stroke: the PRoFESS study: was the baby thrown out with the bathwater? Stroke, 2009, Volume: 40, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hypertension; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Treatment Outcome	2009
Telmisartan for prevention of cardiovascular events. The New England journal of medicine, 2009, Jan-15, Volume: 360, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Diabetes Complications; Humans; Hypertension; Secondary Prevention; Stroke; Telmisartan	2009
Telmisartan for prevention of cardiovascular events. The New England journal of medicine, 2009, Jan-15, Volume: 360, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cerebral Hemorrhage; Humans; Hypertension; Secondary Prevention; Stroke; Telmisartan	2009
Telmisartan for prevention of cardiovascular events. The New England journal of medicine, 2009, Jan-15, Volume: 360, Issue:3 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Secondary Prevention; Stroke; Telmisartan	2009
Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme. Diabetes research and clinical practice, 2009, Volume: 83, Issue:3 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Glucose; Cardiovascular Diseases; Cognition; Cognition Disorders; Cross-Sectional Studies; Depression; Diabetes Mellitus; Diabetic Angiopathies; Drug Therapy, Combination; Female; Glucose Intolerance; Humans; Male; Middle Aged; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Telmisartan	2009
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading? Blood pressure, 2009, Volume: 18, Issue:1-2 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Comorbidity; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Ischemia; Ramipril; Renal Insufficiency; Risk; Stroke; Telmisartan; Treatment Outcome	2009
Correlation of soluble gp130 serum concentrations with arterial blood pressure. Journal of hypertension, 2009, Volume: 27, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Animals; Aorta, Abdominal; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Carotid Arteries; Case-Control Studies; Cell Culture Techniques; Cells, Cultured; Cytokine Receptor gp130; Endothelin-1; Female; Gene Expression; Heart Rate; Humans; Immunohistochemistry; Male; Middle Aged; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Species Specificity; Stroke; Telemetry; Telmisartan; Time Factors; Tunica Intima; Tunica Media; Vasoconstrictor Agents; Young Adult	2009
Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke. Journal of neurotrauma, 2009, Volume: 26, Issue:12 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Brain; Brain Infarction; Brain Ischemia; Cytoprotection; Cytosol; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Motor Cortex; Neurons; Phospholipases A2; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Recovery of Function; Signal Transduction; Stroke; Telmisartan	2009
Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. PloS one, 2011, Volume: 6, Issue:8 Topics: Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Male; Ramipril; Random Allocation; Rats; Rats, Inbred SHR; Rats, Wistar; Stroke; Telmisartan	2011
The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study. Journal of medical economics, 2011, Volume: 14, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cost of Illness; Diabetes Complications; Health Services; Heart Failure; Humans; Multicenter Studies as Topic; Myocardial Infarction; Ramipril; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Telmisartan	2011
Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA, 2011, Nov-16, Volume: 306, Issue:19 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzimidazoles; Benzoates; Blood Pressure; Brain Ischemia; Clopidogrel; Diastole; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Reference Values; Risk; Stroke; Systole; Telmisartan; Ticlopidine; Vascular Diseases	2011
Effects of telmisartan on the cerebral circulation of hypertensive patients with chronic-stage stroke. Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:12 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Cerebrovascular Circulation; Chronic Disease; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Stroke; Telmisartan	2012
[Recurrence prophylaxis for stroke patients. Which platelet inhibitor combination protects best?]. MMW Fortschritte der Medizin, 2003, Jul-24, Volume: 145, Issue:29-30 Topics: Angiotensin II Type 1 Receptor Blockers; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Combinations; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke; Telmisartan; Ticlopidine	2003
[When morning blood pressure increases steeply. Stroke risk also increases]. MMW Fortschritte der Medizin, 2003, Jul-24, Volume: 145, Issue:29-30 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Circadian Rhythm; Humans; Hypertension; Risk Factors; Stroke; Telmisartan	2003
[PRoFESS study presented. Change in secondary prevention]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Aspirin, Dipyridamole Drug Combination; Benzimidazoles; Benzoates; Clopidogrel; Controlled Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Multicenter Studies as Topic; Placebos; Platelet Aggregation Inhibitors; Recurrence; Risk; Stroke; Telmisartan; Ticlopidine; Time Factors	2003
[Therapy of hypertension. Lasting organ protection moves into the foreground]. MMW Fortschritte der Medizin, 2003, Nov-20, Volume: 145, Issue:47 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Myocardial Infarction; Ramipril; Receptor, Angiotensin, Type 1; Stroke; Telmisartan; Treatment Outcome	2003
[Angiotensin II antagonism. Critical morning hours are covered]. MMW Fortschritte der Medizin, 2001, Feb-22, Volume: 143, Issue:8 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Circadian Rhythm; Humans; Hypertension; Myocardial Infarction; Stroke; Telmisartan	2001